Advanced search
Publication Cover
Annals of Medicine Volume 28, 1996 - Issue 3
Submit an article Journal homepage
51
Views
47
CrossRef citations to date
0
Altmetric
Original Article

New Insights into the Genetics of Alzheimer's Disease

John Hardy Suncoast Alzheimer's Disease Laboratory, University of South Florida, Tampa, FL, USA
Pages 255-258 | Published online: 05 Nov 2010

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Doris Lambracht-Washington & Roger N Rosenberg. (2013) Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer’s disease. ImmunoTargets and Therapy 2, pages 105-114.
Read now
David B Henley, Patrick C May, Robert A Dean & Eric R Siemers. (2009) Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease. Expert Opinion on Pharmacotherapy 10:10, pages 1657-1664.
Read now

Articles from other publishers (45)

Karen C. Holdridge, Roy Yaari, Deirdre B. Hoban, Scott Andersen & John R. Sims. (2023) Targeting amyloid β in Alzheimer's disease: Meta‐analysis of low‐dose solanezumab in Alzheimer's disease with mild dementia studies. Alzheimer's & Dementia.
Crossref
Shuangtao Li, Yuanbing Huang, Lijun Yu, Xiaoyu Ji & Jie Wu. (2023) Impact of the Cannabinoid System in Alzheimer's Disease. Current Neuropharmacology 21:3, pages 715-726.
Crossref
Carolina C. Martins, Angélica S. Reis, Ketlyn P. da Motta, Cristiane Luchese & Ethel A. Wilhelm. (2022) Mechanistic pathways of fibromyalgia induced by intermittent cold stress in mice is sex-dependently. Brain Research Bulletin 187, pages 11-23.
Crossref
Chen-Chen Lo, Wen-Te Liu, Yueh-Hsun Lu, Dean Wu, Chih-Da Wu, Ting-Chieh Chen, Yu-Ting Fang, Yu-Chun Lo, You-Yin Chen, Lo Kang, Cheng-Yu Tsai, Yueh-Lun Lee, Kai-Jen Chuang, Kin-Fai Ho, Ta-Yuan Chang & Hsiao-Chi Chuang. (2022) Air pollution associated with cognitive decline by the mediating effects of sleep cycle disruption and changes in brain structure in adults. Environmental Science and Pollution Research 29:35, pages 52355-52366.
Crossref
Roger N. Rosenberg, Doris Lambracht-Washington, Gang Yu & Weiming Xia. 2020. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease 3 18 .
Roger N. Rosenberg, Min Fu & Doris Lambracht-Washington. (2018) Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice. Journal of Neuroimmunology 322, pages 15-25.
Crossref
Balapal S. Basavarajappa, Madhu Shivakumar, Vikram Joshi & Shivakumar Subbanna. (2017) Endocannabinoid system in neurodegenerative disorders. Journal of Neurochemistry 142:5, pages 624-648.
Crossref
Jorge Navarro-Dorado, Nuria Villalba, Dolores Prieto, Begoña Brera, Ana M. Martín-Moreno, Teresa Tejerina & María L. de Ceballos. (2016) Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. Frontiers in Neuroscience 10.
Crossref
T.E. Golde, C.B. Lessard & Y. Ran. 2016. Developing Therapeutics for Alzheimer's Disease. Developing Therapeutics for Alzheimer's Disease 77 96 .
Doris Lambracht-Washington, Bao-xi Qu, Min Fu, Larry D. AndersonJr.Jr., Todd N. Eagar, Olaf Stüve & Roger N. Rosenberg. (2013) A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease. Journal of Neuroimmunology 254:1-2, pages 63-68.
Crossref
Doris Lambracht-Washington & Roger Rosenberg. (2012) Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease. Translational Neuroscience 3:4.
Crossref
Alena V Savonenko, Tatiana Melnikova, Andrew Hiatt, Tong Li, Paul F Worley, Juan C Troncoso, Phil C Wong & Don L Price. (2011) Alzheimer's Therapeutics: Translation of Preclinical Science to Clinical Drug Development. Neuropsychopharmacology 37:1, pages 261-277.
Crossref
Doris Lambracht-Washington, Bao-Xi Qu, Min Fu, Larry D. AndersonJrJr, Olaf Stüve, Todd N. Eagar & Roger N. Rosenberg. (2011) DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer’s Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation. Cellular and Molecular Neurobiology 31:6.
Crossref
Bon D. KuShin Gyeom KimJun-Young LeeKee Hyung ParkJoon Hyun ShinKwang Ki KimYoung Chul YounYung Min LeeChang Hyung HongSang Won SeoDuk L. NaSung Yoon KimHae-Kwan CheongDoh Kwan KimJae-Hong LeeSangYun KimByeong Kil YeonSoo Young KimSeol-Heui Han. (2011) Clinical practice guideline for dementia by Clinical Research Center for Dementia of South Korea. Journal of the Korean Medical Association 54:8, pages 861.
Crossref
Ligang Wang, Haruhisa Sato, Shiguang Zhao & Ikuo Tooyama. (2010) Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease. Neuroscience Letters 481:3, pages 164-167.
Crossref
Robin Roychaudhuri, Mingfeng Yang, Minako M. Hoshi & David B. Teplow. (2009) Amyloid β-Protein Assembly and Alzheimer Disease. Journal of Biological Chemistry 284:8, pages 4749-4753.
Crossref
David R. Borchelt & Alena V. Savonenko. 2008. Handbook of Episodic Memory. Handbook of Episodic Memory 553 573 .
Jeffery J. Anderson, Greg Holtz, Patricia P. Baskin, Mary Turner, Blake Rowe, Bowei Wang, Maria Z. Kounnas, Bruce T. Lamb, Donna Barten, Kevin Felsenstein, Ian McDonald, Kumar Srinivasan, Ben Munoz & Steven L. Wagner. (2005) Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897. Biochemical Pharmacology 69:4, pages 689-698.
Crossref
Hui Zheng. 2004. Amyloid Precursor Protein. Amyloid Precursor Protein.
C.V.C. Prasad, Shikha Vig, David W. Smith, Qi Gao, Craig T. Polson, Jason A. Corsa, Valerie L. Guss, Alice Loo, Donna M. Barten, Ming Zheng, Kevin M. Felsenstein & Susan B. Roberts. (2004) 2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of γ-secretase. Bioorganic & Medicinal Chemistry Letters 14:13, pages 3535-3538.
Crossref
C.V.C Prasad, Jeffrey W Noonan, Charles P Sloan, Wai Lau, Shikha Vig, Michael F Parker, David W Smith, Steven B Hansel, Craig T Polson, Donna M Barten, Kevin M Felsenstein & Susan B Roberts. (2004) Hydroxytriamides as potent γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters 14:8, pages 1917-1921.
Crossref
Dale Schenk. (2002) Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nature Reviews Neuroscience 3:10, pages 824-828.
Crossref
Tammy A. Maldonado, Richard E. Jones & David O. Norris. (2002) Timing of neurodegeneration and beta‐amyloid (Aβ) peptide deposition in the brain of aging kokanee salmon. Journal of Neurobiology 53:1, pages 21-35.
Crossref
H. F. Dovey, V. John, J. P. Anderson, L. Z. Chen, P. De Saint Andrieu, L. Y. Fang, S. B. Freedman, B. Folmer, E. Goldbach, E. J. Holsztynska, K. L. Hu, K. L. Johnson‐Wood, S. L. Kennedy, D. Kholodenko, J. E. Knops, L. H. Latimer, M. Lee, Z. Liao, I. M. Lieberburg, R. N. Motter, L. C. Mutter, J. Nietz, K. P. Quinn, K. L. Sacchi, P. A. Seubert, G. M. Shopp, E. D. Thorsett, J. S. Tung, J. Wu, S. Yang, C. T. Yin, D. B. Schenk, P. C. May, L. D. Altstiel, M. H. Bender, L. N. Boggs, T. C. Britton, J. C. Clemens, D. L. Czilli, D. K. Dieckman‐McGinty, J. J. Droste, K. S. Fuson, B. D. Gitter, P. A. Hyslop, E. M. Johnstone, W‐Y. Li, S. P. Little, T. E. Mabry, F. D. Miller, B. Ni, J. S. Nissen, W. J. Porter, B. D. Potts, J. K. Reel, D. Stephenson, Y. Su, L. A. Shipley, C. A. Whitesitt, T. Yin & J. E. Audia. (2009) Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain. Journal of Neurochemistry 76:1, pages 173-181.
Crossref
M. Pérez, R. Cuadros, M.A. Smith, G. Perry & J. Avila. (2000) Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Letters 486:3, pages 270-274.
Crossref
Eugene D Thorsett & Lee H Latimer. (2000) Therapeutic approaches to Alzheimer’s disease. Current Opinion in Chemical Biology 4:4, pages 377-382.
Crossref
Sanja Stanković, Sanja Glišic & Dragan Alavanatić. (2000) The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population. cclm 38:6, pages 539-544.
Crossref
Bart De Strooper & Wim Annaert. (2000) COMMENTARY: Proteolytic processing and cell biological functions of the amyloid precursor protein. Journal of Cell Science 113:11, pages 1857-1870.
Crossref
Amelia Marutle, Ulrika Warpman, Nenad Bogdanovic, Lars Lannfelt & Agneta Nordberg. (2008) Neuronal Nicotinic Receptor Deficits in Alzheimer Patients with the Swedish Amyloid Precursor Protein 670/671 Mutation. Journal of Neurochemistry 72:3, pages 1161-1169.
Crossref
Tammy A. Maldonado, Richard E. Jones & David O. Norris. (2000) Distribution of β-amyloid and amyloid precursor protein in the brain of spawning (senescent) salmon: a natural, brain-aging model. Brain Research 858:2, pages 237-251.
Crossref
Kenneth S. Kosik, Stephen G. Post & Kimberly A. Quaid. 2000. Early Diagnosis of Alzheimer’s Disease. Early Diagnosis of Alzheimer’s Disease 317 327 .
Michael D. Kaytor & Stephen T. Warren. (1999) Aberrant Protein Deposition and Neurological Disease. Journal of Biological Chemistry 274:53, pages 37507-37510.
Crossref
Dale Schenk, Robin Barbour, Whitney Dunn, Grace Gordon, Henry Grajeda, Teresa Guido, Kang Hu, Jiping Huang, Kelly Johnson-Wood, Karen Khan, Dora Kholodenko, Mike Lee, Zhenmei Liao, Ivan Lieberburg, Ruth Motter, Linda Mutter, Ferdie Soriano, George Shopp, Nicki Vasquez, Christopher Vandevert, Shannan Walker, Mark Wogulis, Ted Yednock, Dora Games & Peter Seubert. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:6740, pages 173-177.
Crossref
Christian Behl. (1999) Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Progress in Neurobiology 57:3, pages 301-323.
Crossref
A. Bianchetti & M. Trabucchi. 1999. Dementias. Dementias 77 101 .
M. Hüll, J. Bauer & M. Daffertshofer. 1999. Klinische Neurologie. Klinische Neurologie 829 856 .
Brent A. Vogt, Alex Martin, Kent E. Vrana, John R. Absher, Leslie J. Vogt & Patrick R. Hof. 1999. Cerebral Cortex. Cerebral Cortex 553 601 .
Karen Duff. (1998) Recent work on Alzheimer's disease transgenics. Current Opinion in Biotechnology 9:6, pages 561-564.
Crossref
Spencer Luiz Marques Payão, Marı́lia de Arruda Cardoso Smith, Lucile Maria Floeter Winter & Paulo Henrique Ferreira Bertolucci. (1998) Ribosomal RNA in Alzheimer's disease and ageing. Mechanisms of Ageing and Development 105:3, pages 265-272.
Crossref
Brent A. Vogt, Leslie J. Vogt, Kent E. Vrana, Lynda Gioia, Robert S. Meadows, Venkat R. Challa, Patrick R. Hof & Gary W. Van Hoesen. (1998) Multivariate Analysis of Laminar Patterns of Neurodegeneration in Posterior Cingulate Cortex in Alzheimer's Disease. Experimental Neurology 153:1, pages 8-22.
Crossref
Kimmo Hatanpää, Krish Chandrasekaran, Daniel R. Brady & Stanley I. Rapoport. (1998) No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Molecular Brain Research 59:1, pages 13-21.
Crossref
Brian H. Anderton. (1997) Changes in the ageing brain in health and disease. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 352:1363, pages 1781-1792.
Crossref
Lawrence S. Honig. (1997) Genetics of Alzheimer's Disease. Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders 7:4, pages 6-10.
Crossref
G B Frisoni & M Trabucchi. (1997) Clinical rationale of genetic testing in dementia.. Journal of Neurology, Neurosurgery & Psychiatry 62:3, pages 217-221.
Crossref
Thomas Wisniewski, Jorge Ghiso & Blas Frangione. (1997) Biology of Aβ Amyloid in Alzheimer's Disease. Neurobiology of Disease 4:5, pages 313-328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.